ACT Together: Using Technology to Facilitate Service Integration for Individuals with Psychiatric Disabilities led by Sarah Lord, PhD was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Administration for Community Living. This project aims to develop and apply a technology platform for delivery of Assertive Community Treatment (ACT) to individuals with serious psychiatric disability.
Mindful Moms in Recovery (MMORE): Yoga-based Mindfulness Relapse Prevention for Pregnant Women with Opioid Disorder led by Sarah Lord, PhD was funded by the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health. Co-led by Daisy Goodman CNM, DNP, MPH, “Mindful Moms in Recovery (MMORE): Yoga-based Mindfulness Relapse Prevention for Pregnant Women with Opioid Disorder” aims to test a yoga-based mindfulness relapse prevention program on pregnant women in their second or early third trimester who are on medication treatment of opioid use disorder.
Moms in Recovery (MORE): Defining Optimal Care for Pregnant Women and Infants, funded by the Patient-Centered Outcomes Research Institute (PCORI) and co-led by Sarah Lord, PhD and Daisy Goodman CNM, DNP, MPH, aims to provide new insights into models of care that may be most effective for mothers with opioid use disorders and their infants and includes a broad multi-disciplinary team and a tri-state partner network (across NH, VT and ME), including behavioral health researchers, women in recovery from opioid use disorders, maternity care and addiction treatment providers, pediatricians, maternity care practice administrators, and state policy stakeholders.
Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services. Jeffrey D. Klausner, MD, MPH of UCLA along with CTBH Center Director, Lisa Marsch, and a team from the NIDA Clinical Trials Network / Office of AIDS Research have launched a new study, entitled “Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services”. This study aims to adapt existing social media-based HIV self-testing and pre-exposure prophylaxis (PrEP) advertising materials for digital distribution and to compare the effectiveness of popular social media sites like Facebook, Grindr, and Hornet with information sites such as Google for promoting HIV self-testing and PrEP uptake among high risk populations.
Improving Colorectal Cancer Screening and Risk Assessment through Deep Learning on Medical Images and Records. Saeed Hassanpour, PhD was recently awarded a grant from the NIH National Library of Medicine Express Research Grants in Biomedical Informatics for 2019-2023. “Improving Colorectal Cancer Screening and Risk Assessment through Deep Learning on Medical Images and Records” seeks to develop a novel, automated bioinformatics approach to colorectal cancer screening through improved accuracy and efficiency in the detection and classification of colorectal polyps, potential precursors to colorectal cancer.
Opioid Use Disorder Phenotyping Feasibility for Clinical Trials. Kathleen Carroll, PhD (Yale University), Lisa A. Marsch, PhD (CTBH Director, Dartmouth College), and Cynthia Campbell, PhD (Kaiser Health Systems) will co-lead a new project with a broad interdisciplinary team on opioid use disorder phenotyping via a new award from the National Institute on Drug Abuse (NIDA) Clinical Trials Network.
This project aims to provide a phenotypic characterization of a heterogenous sample of patients being treated for opioid use disorder (OUD) and provide new insights into their clinical trajectories. The digital phenotyping component of this study, led by CTBH, plans to obtain moment-by-moment quantification of an array of individual-level data, collected via passive mobile sensing and active responses to queries on mobile devices as well as social media activity. The aim of the digital phenotyping study is to understand if/how well data that are digitally-captured as individuals move through their daily lives predict treatment outcomes (including treatment retention and opioid use events) and/or healthcare utilization.
More information on the above projects, and other active CTBH projects, can be found here.